Profile of Metastatic Lung Cancer Patients Susceptible to Development of Thromboembolism During Immunotherapy

Highlights•Lung cancer patients have a high probability of developing thromboembolism (TE) •TE is associated with a poor prognosis •The characteristics of patients developing TE during immunotherapy are unclear •A history of TE and poor PS were associated with a high odds ratio of developing TE •The...

Full description

Saved in:
Bibliographic Details
Published in:Cancer treatment and research communications 2022, Vol.31, p.100547-100547, Article 100547
Main Authors: Endo, Satoshi, Honda, Takayuki, Kawahara, Tatsuo, Sakakibara, Rie, Mitsumura, Takahiro, Okamoto, Tsukasa, Miyazaki, Yasunari
Format: Article
Language:English
Subjects:
Chemotherapy
Hematology, Oncology, and Palliative Medicine
History of TE
Immuno-oncology drugs
Thromboembolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights•Lung cancer patients have a high probability of developing thromboembolism (TE) •TE is associated with a poor prognosis •The characteristics of patients developing TE during immunotherapy are unclear •A history of TE and poor PS were associated with a high odds ratio of developing TE •The results might enable prediction of patients at high risk of TE
ISSN:2468-2942
2468-2942
DOI:10.1016/j.ctarc.2022.100547